Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
August 12, 2022 Off

Therapeutic Solutions International Reports Superior Efficacy of ApoptoCyte™ on Chronic Obstructive Pulmonary Disease Model Compared to Conventional Stem Cell Approaches

By BusinessWire

Phase III Clinical Stage Company Demonstrates Superior Efficacy of Proprietary Stem Cell Apoptotic Body Based Drug ELK CITY, Idaho–(BUSINESS WIRE)–Therapeutic…

August 12, 2022 Off

PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights

By BusinessWire

MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization…

August 12, 2022 Off

AmerisourceBergen Hosts Inaugural Disparities in Cancer Care Summit

By BusinessWire

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–AmerisourceBergen (AB), a global healthcare company and leader in specialty pharmaceutical services and distribution for more than 20…

August 12, 2022 Off

Global Cancer Supportive Care Drugs Market Report 2022-2027: Rising Disposable Incomes and Constant Improvements in Healthcare & Increasing Prevalence of Cancer to Drive Growth – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Supportive Care Drugs Market (2022-2027) by Drug Class, Applications, Distribution Channel, Geography, Competitive Analysis and the…

August 12, 2022 Off

FDA Approves First NGS-Based Companion Diagnostic to Aid in Selecting Non-Small Cell Lung Cancer Patients with HER2 (ERBB2) Activating Mutations (SNVs & Exon 20 Insertions) for Treatment with ENHERTU

By BusinessWire

This approval marks the Oncomine Dx Target Test’s 8th CDx therapy selection indication CARLSBAD, Calif.–(BUSINESS WIRE)–The U.S. Food and Drug…

August 12, 2022 Off

Axcella Reports Second Quarter Financial Results and Provides Business Update

By BusinessWire

Announced Statistically Significant Clinical Improvement in Fatigue in the Phase 2A Long COVID Trial Topline data NASH Trial interim Data…

August 12, 2022 Off

Global Hematology Analyzers Market Research Report to 2027 – Players Include Boule Diagnostics, Cellavision, Drucker Diagnostics and Edan Instruments Among Others – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Hematology Analyzers Market Research Report by Product Type, Price Range, End User, Region – Global Forecast to 2027…

August 12, 2022 Off

Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants

By BusinessWire

Pivotal top-line data demonstrate a four-dose series of 20-valent pneumococcal conjugate vaccine candidate (20vPnC), if approved, would provide the broadest…

August 12, 2022 Off

Insights on the Chiral Chromatography Column Global Market to 2027 – Developments and Technological Advancements in Chromatography Instruments Presents Opportunities – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Chiral Chromatography Column Market Research Report by Product Type (Empty Column and Prepacked Column), Material Type, Technology, End-User,…

August 12, 2022 Off

Tardive Dyskinesia (TD) Treatment Drugs Market Report 2022: Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2029 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Tardive Dyskinesia (TD) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive…

Posts navigation

Previous 1 2 3 … 4,126 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Plus Therapeutics Presents Positive Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain Metastases

August 14, 2022 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off
Proudly powered by WordPress | Theme: Envo Magazine